1.
Di Brizzi EV, Buononato D, Benvenuto P, Argenziano G, De Pasquale R, Fiorella CS, et al. Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis. Dermatol Pract Concept [Internet]. 2023 Oct. 31 [cited 2026 May 12];13(4):e2023215. Available from: https://dpcj.org/index.php/dpc/article/view/3114